Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity
- PMID: 10429242
- DOI: 10.1038/11710
Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity
Abstract
Programmable fusogenic vesicles (PFVs) are lipid-based drug-delivery systems that exhibit time-dependent destabilization. The rate at which this destabilization occurs is determined by the exchange rate of a bilayer-stabilizing component, polyethylene glycol-phosphatidylethanolamine (PEG-PE) from the vesicle surface. This exchange rate is controlled, in turn, by the acyl chain composition of the PEG-PE. We describe in vitro and in vivo studies using PFVs as delivery vehicles for the anticancer drug mitoxantrone. We demonstrate that the PEG-PE acyl composition determined the rate at which PFVs are eliminated from plasma after intravenous administration, and the rate of mitoxantrone leakage from PFV. The nature of the PEG-PE component also determined the antitumor efficacy of mitoxantrone-loaded PFV in murine and human in murine and human xenograft tumor models. Increased circulation time and improved activity were obtained for PFV containing PEG-PE with an 18-carbon acyl chain length, as a result of slower vesicle destabilization.
Similar articles
-
Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone.Int J Pharm. 2008 Oct 1;362(1-2):60-6. doi: 10.1016/j.ijpharm.2008.06.008. Epub 2008 Jun 13. Int J Pharm. 2008. PMID: 18598745
-
Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.J Dermatol Sci. 2007 Apr;46(1):11-20. doi: 10.1016/j.jdermsci.2006.12.011. Epub 2007 Jan 30. J Dermatol Sci. 2007. PMID: 17267180
-
Encapsulation of mitoxantrone into pegylated SUVs enhances its antineoplastic efficacy.Eur J Pharm Biopharm. 2008 Oct;70(2):657-65. doi: 10.1016/j.ejpb.2008.05.019. Epub 2008 Jun 6. Eur J Pharm Biopharm. 2008. PMID: 18582570
-
Aza and diaza bioisosteric anthracene-9,10-diones as antitumor agents.Acta Biochim Pol. 1995;42(4):427-32. Acta Biochim Pol. 1995. PMID: 8852333 Review.
-
Mathematical modeling of vesicle drug delivery systems 2: targeted vesicle interactions with cells, tumors, and the body.J Lab Autom. 2013 Feb;18(1):46-62. doi: 10.1177/2211068212458265. Epub 2012 Sep 18. J Lab Autom. 2013. PMID: 22989771 Review.
Cited by
-
Mitoxantrone-Surfactant Interactions: A Physicochemical Overview.Molecules. 2016 Oct 13;21(10):1356. doi: 10.3390/molecules21101356. Molecules. 2016. PMID: 27754390 Free PMC article. Review.
-
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.Adv Drug Deliv Rev. 2012 Jan;64(1):29-39. doi: 10.1016/j.addr.2011.04.006. Epub 2011 May 3. Adv Drug Deliv Rev. 2012. PMID: 21569804 Free PMC article. Review.
-
Lipid-based nucleic acid therapeutics with in vivo efficacy.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Mar;15(2):e1856. doi: 10.1002/wnan.1856. Epub 2022 Sep 30. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 36180107 Free PMC article. Review.
-
Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics.Mol Pharm. 2012 Nov 5;9(11):3266-76. doi: 10.1021/mp300326z. Epub 2012 Oct 3. Mol Pharm. 2012. PMID: 23030381 Free PMC article.
-
Sheddable coatings for long-circulating nanoparticles.Pharm Res. 2008 Jan;25(1):55-71. doi: 10.1007/s11095-007-9348-7. Epub 2007 Jun 6. Pharm Res. 2008. PMID: 17551809 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
